Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 2,000 shares at $45.13 ($90K) on 2023-09-26, disclosed to the SEC on 2023-09-28.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |